NR4A1 and neoplasm: Patients undergoing upfront surgery had higher proportions of hormone receptor-positive (HR+)/HER2− and triple-negative receptor status (p < 0.001), had lower clinical (cT) [p < 0.0001] and pathologic (pT) tumor stage (p < 0.0001) and less frequent nodal involvement (pathologic N [pN] stage 0 disease) [p < 0.0001], and underwent lumpectomy at higher proportions (49.53% vs. 33.25%; p < 0.0001).